Federica COLLINO | Research associated | PhD | University of Milan, Milan | UNIMI | Department of Clinical Sciences and Community Health | Research profile
attivazione linfociti t
LA PODISTICA TORINO SBANCA PINEROLO
Colture cellulari 3D per decifrare il tumore del seno | Fondazione Umberto Veronesi
Federica Collino - Vialibera Cuneo
Pharmaceutics | Free Full-Text | Biodistribution of Intratracheal, Intranasal, and Intravenous Injections of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles in a Mouse Model for Drug Delivery Studies
continua - Atletica Val Pellice
Staff Amministrazione - Stilcar SpA concessionaria ufficiale Citroen provincia di Torino
Federica Collino - Associate Researcher - Università degli Studi di Milano | LinkedIn
Montini Lab - INGM
Vittorio Alfieri Asti ok al Giro delle Borgate di Mattie - SportAsti
Collino Federica | Università degli Studi di Milano Statale
Extracellular Vesicles Released from Mesenchymal Stromal Cells Modulate miRNA in Renal Tubular Cells and Inhibit ATP Depletion I
Massimo COLLINO | Professor (Associate) | PhD | Università degli Studi di Torino, Turin | UNITO | Dipartimento di Scienza e Tecnologia del Farmaco | Research profile
Intrinsic and Extrinsic Modulators of the Epithelial to Mesenchymal Transition: Driving the Fate of Tumor Microenvironment
Cardiac Overexpression of Melusin Protects From Dilated Cardiomyopathy Due to Long-Standing Pressure Overload
Federica Collino - Associate Researcher - Università degli Studi di Milano | LinkedIn
Federica Collino | Policlinico di Milano
HLSC – Page 2 – Unicyte
Renal Regenerative Potential of Different Extracellular Vesicle Populations Derived from Bone Marrow Mesenchymal Stromal Cells
Federica Accornero | Ohio State University - Nationwide Children's Hospital Center for Muscle Health and Neuromuscular Disorders
Loop | Federica Collino
La Vittorio Alfieri Asti si laurea campione regionale di Km verticale - SportAsti
Graziano Collino
Paolo Bert e Federica Collino inaugurano il Trail del Chisone – Baudenasca (TO) | Running Passion
CD133+ cells as a therapeutic target for kidney diseases